Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
1,181,608
Value
$96.3M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ARWR by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,181,608$96.3M<0.1%+573,077+94.2%AddedHolders
Q1 2026608,531$38.1M<0.1%+461,119+312.8%AddedHolders
Q4 2025147,412$9.79M<0.1%−327,050−68.9%ReducedHolders
Q3 2025474,462$16.4M<0.1%+107,751+29.4%AddedHolders
Q2 2025366,711$5.79M<0.1%+366,711NewHolders
Q1 20250$00.0%−35,666−100.0%Sold outHolders
Q4 202435,666$670.5K<0.1%−86,214−70.7%ReducedHolders
Q3 2024121,880$2.36M<0.1%−23,994−16.4%ReducedHolders
Q2 2024145,874$3.79M<0.1%+84,867+139.1%AddedHolders
Q1 202461,007$1.74M<0.1%−486,779−88.9%ReducedHolders
Q4 2023547,786$16.8M<0.1%−140,125−20.4%ReducedHolders
Q3 2023687,911$18.5M<0.1%+333,516+94.1%AddedHolders
Q2 2023354,395$12.6M<0.1%+354,395NewHolders
Q1 20230$00.0%−16,759−100.0%Sold outHolders
Q4 202216,759$680.0K<0.1%00.0%UnchangedHolders
Q3 202216,759$554.0K<0.1%−18,184−52.0%ReducedHolders
Q2 202234,943$1.23M<0.1%−23,276−40.0%ReducedHolders
Q1 202258,219$2.68M<0.1%−63,070−52.0%ReducedHolders
Q4 2021121,289$8.04M<0.1%−36,801−23.3%ReducedHolders
Q3 2021158,090$9.87M<0.1%−61,498−28.0%ReducedHolders
Q2 2021219,588$18.2M<0.1%+6,512+3.1%AddedHolders
Q1 2021213,076$14.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.